Velagliflozin proline |
| Catalog No.GC70113 |
Velagliflozin proline is an orally administered sodium-glucose co-transporter 2 (SGLT2) inhibitor with anti-diabetic activity. Specifically, Velagliflozin proline reduces renal glucose reabsorption, promotes glucosuria, and thereby lowers blood glucose and insulin concentrations.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1539295-26-5
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Review for Velagliflozin proline
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
Review for Velagliflozin proline
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *